Expression of ABCA4 in Retinal Pigment Epithelium cells and its implications for Stargardt disease

被引：0
|
作者：
Lenis, Tamara L. [1 ]
Sarfare, Shanta [2 ]
Hu, Jane [1 ]
Jiang, Zhichun [1 ]
Lloyd, Marcia [1 ]
Bok, Dean [1 ]
Travis, Gabriel H. [1 ]
Radu, Roxana A. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA
[2] New England Coll Optometry, Boston, MA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
607
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Impaired cathepsin D in retinal pigment epithelium cells mediates Stargardt disease pathogenesis
    Ng, Eunice Sze Yin
    Hu, Jane
    Jiang, Zhichun
    Radu, Roxana A.
    FASEB JOURNAL, 2024, 38 (11):
  • [42] QR-1011 restores defective ABCA4 splicing caused by multiple severe ABCA4 variants underlying Stargardt disease
    Kaltak, Melita
    de Bruijn, Petra
    van Leeuwen, Willemijn
    Platenburg, Gerard
    Cremers, Frans P. M.
    Collin, Rob W. J.
    Swildens, Jim
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [43] ABCA4 variants in Stargardt disease: Preliminary results from the ProgStar study
    Bomotti, Samantha
    Strauss, Rupert Wolfgang
    Scholl, Hendrik P.
    Wojciechowski, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [44] Splice modulation therapy for a variety of ABCA4 mutations underlying Stargardt disease
    Collin, Rob W. J.
    Khan, Mubeen
    Sangermano, Riccardo
    Naessens, Sarah
    Bauwens, Miriam
    Hoyng, Carel C. B.
    Coppieters, Frauke
    Albert, Silvia
    Cheetham, Michael E.
    De Baere, Elfride
    Cremers, Frans P.
    Garanto, Alex
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [45] Detailed Phenotyping and Therapeutic Strategies for Intronic ABCA4 Variants in Stargardt Disease
    Khan, Mubeen
    Arno, Gavin
    Fakin, Ana
    Parfitt, David A.
    Dhooge, Patty P. A.
    Albert, Silvia
    Bax, Nathalie M.
    Duijkers, Lonneke
    Niblock, Michael
    Hau, Kwan L.
    Bloch, Edward
    Schiff, Elena R.
    Piccolo, Davide
    Hogden, Michael C.
    Hoyng, Carel B.
    Webster, Andrew R.
    Cremers, Frans P. M.
    Cheetham, Michael E.
    Garanto, Alejandro
    Collin, Rob W. J.
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 21 : 412 - 427
  • [46] Novel compound heterozygous mutations in ABCA4 in a Chinese pedigree with Stargardt disease
    Zhang, Jianping
    Qi, Anhui
    Wang, Xi
    Pan, Hong
    Mo, Haiming
    Huang, Jiwei
    Li, Honghui
    Chen, Zhenwen
    Wei, Meirong
    Wang, Binbin
    MOLECULAR VISION, 2016, 22 : 1514 - 1521
  • [47] Personalized recurrence risks in Stargardt disease based on ABCA4 variant severity
    Cornelis, Stephanie Susanne
    Runhart, Esmee
    Bauwens, Miriam
    Corradi, Zelia
    De Baere, Elfride
    Roosing, Susanne
    Haer-Wigman, Lonneke
    Dhaenens, Claire-Marie
    Vulto-van Silfhout, Anneke T.
    Cremers, Frans P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [48] Molecular diagnostics of Stargardt disease by genotyping patients on the ABCR (ABCA4) microarray
    Zernant, J
    Jaakson, K
    Lewis, RA
    Glavac, D
    Caruso, R
    Gouras, P
    Simonelli, F
    Lupski, JR
    Cremers, FPM
    Allikmets, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U712 - U712
  • [49] Enrichment of a deep intronic ABCA4 variant in Irish Stargardt disease patients
    Whelan, Laura
    Dockery, A.
    Khan, M.
    Corradi, Z.
    Cornelis, S. S.
    Wynne, N.
    O' Byrne, J. J.
    Zhu, J.
    Stephenson, K.
    Turner, J.
    Silvestri, G.
    Keegan, D.
    Kenna, P. F.
    Roosing, S.
    Dhaenens, C. M.
    Cremers, F. P. M.
    Farrar, G. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 2) : 66 - 66
  • [50] Splicing modulation therapy for a variety of ABCA4 mutations underlying Stargardt disease
    Garanto, A.
    Tomkiewicz, T. Z.
    Suarez-Herrera, N.
    Khan, M.
    Sangermano, R.
    Bauwens, M.
    Naessens, S.
    De Baere, E.
    Cheetham, M. E.
    Cremers, F. P. M.
    Collin, R. W. J.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A74 - A74
12345